Technology
Health
Biotechnology
NuCana
$14.939876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$14.93
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
$0.00 (0.00%) Today
$0.00 (0.00%) Today
Why Robinhood?
You can buy or sell NuCana and other stocks, options, ETFs, and crypto commission-free!
About
NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology is consists of acelarin, NUC-3373, and NUC-7738. Read More The company was founded by Hugh S. Griffith and Christopher B. Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.
Employees
24
Headquarters
Edinburgh, Midlothian
Founded
1997
Market Cap
473.68M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
52.01K
High Today
—
Low Today
—
Open Price
—
Volume
0.00
52 Week High
$32.00
52 Week Low
$10.37
Collections
Technology
Health
Biotechnology
Cancer Prevention
2017 IPO
UK
Europe
Price Paid on Robinhood
9% Lower
Right Now
52 Week Low
$10.37
Average Price Paid
$16.50
52 Week High
$32.00
Earnings
-$21.52
-$14.36
-$7.21
-$0.05
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
-$0.17 per share